Adma Biologics (ADMA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
20.26 -0.02 (-0.10%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 20.15 -0.11 (-0.54%) 19:38 ET
for Fri, Mar 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 197,673 | -28,239 | -65,904 | -71,648 | -75,749 |
| Depreciation Amortization | 8,853 | 10,783 | 9,372 | 7,250 | 5,582 |
| Income taxes - deferred | -84,280 | N/A | N/A | N/A | N/A |
| Accounts receivable | -22,578 | -11,916 | 13,072 | -15,340 | -9,767 |
| Accounts payable and accrued liabilities | 4,150 | 3,839 | 800 | 1,356 | 1,899 |
| Other Working Capital | -18,539 | -10,123 | -18,286 | -51,680 | -33,781 |
| Other Operating Activity | 33,393 | 44,456 | 1,438 | 17,693 | 9,813 |
| Operating Cash Flow | $118,672 | $8,800 | $-59,508 | $-112,369 | $-102,003 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,226 | -4,771 | -13,911 | -13,511 | -12,725 |
| Purchase Sale Intangibles | -349 | -210 | N/A | N/A | N/A |
| Other Investing Activity | -349 | -210 | 0 | 0 | 0 |
| Investing Cash Flow | $-8,575 | $-4,981 | $-13,911 | $-13,511 | $-12,725 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 135,000 | 151,750 | N/A | 27,500 |
| Debt Repayment | -60,825 | -171,327 | -102,036 | -34 | -14,812 |
| Common Stock Issued | 7,494 | 1,104 | 64,820 | 121,144 | 131,209 |
| Other Financing Activity | -4,971 | -3,766 | -5,682 | -62 | 0 |
| Financing Cash Flow | $-58,302 | $-38,989 | $108,852 | $121,048 | $143,897 |
| Beginning Cash Position | 51,352 | 86,522 | 51,089 | 55,921 | 26,752 |
| End Cash Position | 103,147 | 51,352 | 86,522 | 51,089 | 55,921 |
| Net Cash Flow | $51,795 | $-35,170 | $35,433 | $-4,832 | $29,169 |
| Free Cash Flow | |||||
| Operating Cash Flow | 118,672 | 8,800 | -59,508 | -112,369 | -102,003 |
| Capital Expenditure | -8,226 | -4,771 | -13,911 | -13,511 | -12,727 |
| Free Cash Flow | 110,446 | 4,029 | -73,419 | -125,880 | -114,730 |